J Pediatr Infect Dis
DOI: 10.1055/s-0044-1791522
Original Article

Deregulated Expression of Long Non-coding RNA ZFAS1 as a Predictive Biomarker for Respiratory Failure in Severe Pneumonia Children and Its Impact on Clinical Outcome

Huaying Zhu
1   Department of Radiological Nursing, Shaoxing Second Hospital Medical Community General Hospital, Shaoxing, China
,
2   Department of Neonatology, Zhuji Maternal and Child Health Hospital, Zhuji, China
› Author Affiliations

Abstract

Objective Severe pneumonia is a common pediatric disease, often complicated by respiratory failure (RF). The expression changes of long non-coding RNA zinc finger antisense 1 (ZFAS1) were examined in children with severe pneumonia, as well as their predictive value in the occurrence of RF and poor outcomes.

Methods A total of 120 children with severe pneumonia were included, 60 of whom had RF. RT-qPCR was used to detect mRNA levels. Deaths during the follow-up period were recorded through a 28-day follow-up survey. Receiver operating characteristic (ROC) curve and Kaplan Meier (K-M) plot were drawn to display diagnostic and predictive values, with the help of multiple logistic and Cox regression analysis.

Results A sharp rise of serum ZFAS1 was tested in severe pneumonia children, providing a area under the receiver operator characteristic curve (AUC-ROC) of 0.920, with a sensitivity of 81.67% and a specificity of 90.00%. Serum ZFAS1 (OR = 5.832, 95% CI = 2.283–14.899) was found to be associated with the occurrence of RF after adjusting other clinical indexes, with an AUC-ROC of 0.843. ZFAS1 (HR = 4.624, 95% CI = 1.318–16.217, P < 0.05) was an independent influence factor for the poor prognosis. Cases with high ZFAS1 levels had worse clinical outcomes.

Conclusion Monitoring serum ZFAS1 levels is helpful in assessing severe pneumonia in children, especially for early identification of cases with RF. High serum ZFAS1 levels have a certain predictive value for poor prognosis in patients.



Publication History

Received: 12 May 2024

Accepted: 01 September 2024

Article published online:
04 October 2024

© 2024. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • References

  • 1 He J, Yuan R, Cui X. et al. Anemoside B4 protects against Klebsiella pneumoniae- and influenza virus FM1-induced pneumonia via the TLR4/Myd88 signaling pathway in mice. Chin Med 2020; 15: 68
  • 2 Huang C, Zhang C, Zhang J, Zhang L, Mo Y, Mo L. Heparin-binding protein in critically ill children with severe community-acquired pneumonia. Front Pediatr 2021; 9: 759535
  • 3 Rueda ZV, Aguilar Y, Maya MA. et al. Etiology and the challenge of diagnostic testing of community-acquired pneumonia in children and adolescents. BMC Pediatr 2022; 22 (01) 169
  • 4 Li W, An X, Fu M, Li C. Emergency treatment and nursing of children with severe pneumonia complicated by heart failure and respiratory failure: 10 case reports. Exp Ther Med 2016; 12 (04) 2145-2149
  • 5 Wang L, Fan Y, Xu J, Deng H, Geng C, Jia B. The efficacy and safety of Tanreqing injection combined with western medicine for severe pneumonia: a protocol for systematic review and meta-analysis. Medicine (Baltimore) 2020; 99 (35) e22010
  • 6 Hirota K. Preoperative management and postoperative delirium: the possibility of neuroprehabilitation using virtual reality. J Anesth 2020; 34 (01) 1-4
  • 7 de Vasconcelos MGGC, Jarovsky D, Nunes GZ, Tridente DM, Grill JAT, Berezin EN. Molecular diagnostic of complicated pneumonia in the post-vaccine era. J Trop Pediatr 2022; 68 (06) fmac086
  • 8 Munro APS. Molecular diagnostics for invasive lung infections in children. Acta Paediatr 2023; 112 (07) 1368-1370
  • 9 Bridges MC, Daulagala AC, Kourtidis A. LNCcation: lncRNA localization and function. J Cell Biol 2021; 220 (02) e202009045
  • 10 Cui J, Wang J, Lv Y, Xu D. LncRNA NEAT1 regulates infantile pneumonia by sponging miR-146b. Mol Biotechnol 2021; 63 (08) 694-701
  • 11 Sun J, Mao S, Ji W. LncRNA H19 activates cell pyroptosis via the miR-22-3p/NLRP3 axis in pneumonia. Am J Transl Res 2021; 13 (10) 11384-11398
  • 12 Zhang P, Cao L, Zhou R, Yang X, Wu M. The lncRNA Neat1 promotes activation of inflammasomes in macrophages. Nat Commun 2019; 10 (01) 1495
  • 13 Zhou C, Wu D. Abnormal expression of lncRNA CASC9 in pneumonia children with respiratory failure and its feasible value for the clinical diagnosis of patients. Cell Cycle 2022; 21 (17) 1879-1886
  • 14 Chen X, Liu Q, Chen J, Liu Y. LncRNA RP11-248E9.5 and RP11-456D7.1 are valuable for the diagnosis of childhood pneumonia. Int J Gen Med 2021; 14: 895-902
  • 15 Chen P, Huang Z, Chen L. et al. The relationships between LncRNA NNT-AS1, CRP, PCT and their interactions and the refractory mycoplasma pneumoniae pneumonia in children. Sci Rep 2021; 11 (01) 2059
  • 16 Wu W, Zhong W, Xu Q, Yan J. Silencing of long non-coding RNA ZFAS1 alleviates LPS-induced acute lung injury by mediating the miR-96-5p/OXSR1 axis in sepsis. Am J Med Sci 2022; 364 (01) 66-75
  • 17 Yang Y, Tai W, Lu N. et al. lncRNA ZFAS1 promotes lung fibroblast-to-myofibroblast transition and ferroptosis via functioning as a ceRNA through miR-150-5p/SLC38A1 axis. Aging (Albany NY) 2020; 12 (10) 9085-9102
  • 18 Subspecialty Group of Respiratory Diseases TSoPCMA. Editorial Board CJoP. [Guidelines for management of community acquired pneumonia in children (the revised edition of 2013) (I)] [in Chinese]. Zhonghua Er Ke Za Zhi 2013; 51 (10) 745-752
  • 19 Zhou P, Li Z, Gao L. et al. Pulmonary involvement of ANCA-associated vasculitis in adult Chinese patients. BMC Pulm Med 2022; 22 (01) 35
  • 20 Zheng HH, Xiang Y, Wang Y, Zhao QS, Fang R, Dai R. Clinical value of blood related indexes in the diagnosis of bacterial infectious pneumonia in children. Transl Pediatr 2022; 11 (01) 114-119
  • 21 Ning J, Shao X, Ma Y, Lv D. Valuable hematological indicators for the diagnosis and severity assessment of Chinese children with community-acquired pneumonia: prealbumin. Medicine (Baltimore) 2016; 95 (47) e5452
  • 22 Ni J, Lu J, Lu D. Abnormal expression and clinical value analysis of long noncoding RNA cancer susceptibility candidate 2 in children with severe pneumonia complicated with respiratory failure. Clin Respir J 2022; 16 (06) 460-466
  • 23 Tang X, Yin R, Shi H. et al. LncRNA ZFAS1 confers inflammatory responses and reduces cholesterol efflux in atherosclerosis through regulating miR-654-3p-ADAM10/RAB22A axis. Int J Cardiol 2020; 315: 72-80
  • 24 Yang S, Yin W, Ding Y, Liu F. Lnc RNA ZFAS1 regulates the proliferation, apoptosis, inflammatory response and autophagy of fibroblast-like synoviocytes via miR-2682-5p/ADAMTS9 axis in rheumatoid arthritis. Biosci Rep 2020; 40 (08) BSR20201273
  • 25 He C, Su C, Zhang W. et al. Modulatory potential of lncRNA Zfas1 for inflammation and neuronal apoptosis in temporal lobe epilepsy. Yonsei Med J 2021; 62 (03) 215-223
  • 26 Chavez-Galan L, Ruiz A, Martinez-Espinosa K. et al. Circulating levels of PD-L1, TIM-3 and MMP-7 are promising biomarkers to differentiate COVID-19 patients that require invasive mechanical ventilation. Biomolecules 2022; 12 (03) 445
  • 27 Niu BY, Wang G, Li B, Zhen GS, Weng YB. Sequential treatment of severe pneumonia with respiratory failure and its influence on respiratory mechanical parameters and hemodynamics. World J Clin Cases 2022; 10 (21) 7314-7323
  • 28 Guo J, Zhang N, Liu G, Zhang A, Liu X, Zheng J. Upregulated expression of long non-coding RNA MEG3 serves as a prognostic biomarker in severe pneumonia children and its regulatory mechanism. Bioengineered 2021; 12 (01) 7120-7131
  • 29 Li W, An X, Fu M, Li C. Emergency treatment and nursing of children with severe pneumonia complicated by heart failure and respiratory failure: 10 case reports. Exp Ther Med 2016; 2022 (04) 2145-2149
  • 30 Chama M, Amadi BC, Chandwe K. et al. Transcriptomic analysis of enteropathy in Zambian children with severe acute malnutrition. EBioMedicine 2019; 45: 456-463
  • 31 Guo S, Mao X, Liang M. The moderate predictive value of serial serum CRP and PCT levels for the prognosis of hospitalized community-acquired pneumonia. Respir Res 2018; 19 (01) 193